Effects of long-term 4-aminopyridine therapy on glucose tolerance and glucokinetics in patients with spinal cord injury.
Pharmacotherapy
; 27(6): 789-92, 2007 Jun.
Article
en En
| MEDLINE
| ID: mdl-17542761
ABSTRACT
STUDY OBJECTIVE:
To assess the effects of the potassium channel blocker, 4-aminopyridine, on glucose tolerance and glucokinetics in patients with spinal cord injury.DESIGN:
Prospective, dose level-blinded study.SETTING:
University-affiliated, tertiary-level care, Veterans Affairs medical center, and a university-affiliated research center. PATIENTS Thirty-one patients with spinal cord injury of more than 1 year's duration. INTERVENTION In a fasting state, patients ingested 75 g of glucose and completed a 5-hour oral glucose tolerance test before and after 6 months of treatment with an oral, immediate-release formulation of 4-aminopyridine. MEASUREMENTS AND MAINRESULTS:
The time course of glucose plasma concentrations during the oral glucose tolerance tests was profiled for each patient, and glucokinetic parameters were estimated. Results were compared at baseline and after 6 months of treatment with 4-aminopyridine. Of the 31 patients, 29 (94%) had impaired glucose tolerance at baseline. After 6 months of treatment with 4-aminopyridine, 12 (41%) of the 29 patients had a 2-hour postprandial glucose level that no longer supported a diagnosis of impaired glucose tolerance. No significant changes or clinically important trends were seen in fasting blood glucose concentrations or in other glucokinetic parameters in these patients.CONCLUSIONS:
The long-term administration of an oral, immediate-release formulation of 4-aminopyridine to patients with longstanding spinal cord injury was associated with readily discernible, potentially clinically significant improvements in glucose tolerance. Because impaired glucose tolerance is a common finding in patients with spinal cord injury, more research, including randomized controlled trials with large study populations, is warranted on this potential treatment.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Traumatismos de la Médula Espinal
/
4-Aminopiridina
/
Bloqueadores de los Canales de Potasio
/
Glucosa
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Humans
/
Middle aged
Idioma:
En
Año:
2007
Tipo del documento:
Article